Bone Growth Stimulators Market Size, Share, Key Players Overview and Geographical Outlook 2026

Recent innovations and clinical approvals are supporting growth in Global Bone Growth Stimulators Market. With clear pathways for future growth.

In April 2019, a team of analysts at the University of Michigan introduced a theory that High Intensity Focused Ultrasound (HIFU) and gene switches can be of a massive help in stimulating the growth of bones. The HIFU is already clinically approved by the FDA and has shown positive clinical results. This method is set to change the way bone growth stimulators have been operating. When used simultaneously, HIFU and gene switches can speed up growth stimulation processes, thereby taking lesser time for tissue regeneration and healing. Discovery of such methods have led to an increased adoption of bone growth stimulators, worldwide.

Browse Complete Report Details:
https://www.fortunebusinessinsights.com/industry-reports/bone-growth-stimulators-market-100161

• Zimmer Biomet
• Stryker
• Medtronic
• Wright Medical Group N.V.
• Orthofix Holdings, Inc.
• Prospec-Tany Technogene Ltd
• Elizur Corporation
• Bioventus Ossatec
• Benelux BV
• IGEA S.p.a

The Global Bone Growth Stimulators Market is likely to gain traction from recent advancements in tissue regeneration and healing. According to a report by Fortune Business Insights, titled “Bone Growth Stimulators Market Size, Share and Global Trend By Product Type (Bone Growth Stimulation Devices, Bone Morphogenetic Proteins (BMP), Platelet-Derived Growth Factor (PDGF)), By Application (Spinal Fusion, Maxillofacial & Dental, Non-union and Union Bone Fractures), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Home Care), and Geography Forecast till 2026,” the market was valued at US$ 1,837.2 Mn in 2018.

Fortune Business Insights further states that this market will be valued at US$ 2,624.8 Mn by the end of 2026, thereby exhibiting a CAGR of 4.6%.
Long Awaited FDA Approval for Orthfix’s PhysioStim Has Encouraged Market Competitors
In 2018, Orthofix announced that it has received FDA and CE mark approvals for its PhysioStim bone growth stimulators. PhysioStim offered tissue regeneration and recombining without the need to undergo surgical procedures.

The FDA approval for PhysioStim and other such products have encouraged other market players to come up with their own products and improve existing methods. Such drug approvals have a positive impact on the global bone growth stimulators market and is likely to favour growth of this market in the forecast period.

Conventional bone growth stimulators were mostly manufactured using patented drugs. Most of the stimulators were manufactured with the help of very few drug options. But in recent years, newer drugs have been approved for manufacturing and study of bone growth stimulators.

Get Sample Copy:
https://www.fortunebusinessinsights.com/enquiry/sample/bone-growth-stimulators-market-100161

Electrical and Magnetic Field Concept to Boost Operation of Bone Growth Stimulators
The combined magnetic field (mf) concept was hugely beneficial for spinal fusion. Magnetic Field (MF) is used for pre-processing of osteogenesis, where-in tissue regeneration and growth is initiated. Electrical bone growth stimulation is used in patients with bone healing problems. They supplement tissue regeneration which stimulate the spinal fusion and bone growth. Electrical bone growth stimulators play a major part in spinal fusion among patients who possess a higher grade of disorders or in serious cases. Thus, the drawbacks of normal spinal fusion are overcome by electrical and magnetic bone growth stimulators. The benefits of these concepts have a positive impact on the global bone growth stimulators market and is likely to drive the market in the forthcoming years.

Increasing Investment in Research and Development to Boost the Market
The growing investments in research and development of bone growth stimulators is boosting the global market. With increasing awareness about the need for early diagnosis of disorders such as spondylitis and other spinal diseases, there has been a growing emphasis on the research and development of drugs related to bone growth stimulation.

Furthermore, to aid geriatric population, governments across the world have been putting in more efforts to improve health reimbursement policies. The aforementioned factors are likely to favour the growth of the global bone growth stimulators market in the forecast period.

TABLE OF CONTENT:
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4 Market Trends
4. Key Insights
4.1 Number of Spinal Fusion Surgrey - For Key Countries, 2018
4.2 Regulatory Scenario -For Key Countries
4.3 Health Reimbursement Overview
4.4 New Product Launch
4.5 Pipeline Snapshot
4.6 Key Industry Developments - Mergers, Acquisitions and Partnerships
TOC Continued…!

Speak to Analyst:
https://www.fortunebusinessinsights.com/enquiry/queries/bone-growth-stimulators-market-100161

Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

This release was published on openPR.